Annals of the ICRP

A joint Task Group of ICRP Committees 2 (Doses from Radiation Exposures) and 3 (Protection in Medicine; lead Committee for this report) has prepared a compilation of data on radiation dose to patients from radiopharmaceuticals.

The report provides biokinetic models, absorbed doses, and effective doses, using ICRP Publication 60 dosimetry, for 10 new radiopharmaceuticals: [Methyl-¹¹C]thymidine; [2-¹¹C]thymidine; ¹⁴C urea (incl. carbon dioxide and bicarbonate); ¹⁵O water; ^99mTc HIG, Pertechnegas, Technegas, and tetrofosmin; and ¹¹¹In HIG and octreotide.

It also provides recalculated dose data for the 19 most frequently used radiopharmaceuticals from ICRP Publication 53, using ICRP Publication 60 dosimetry, viz. ¹⁸F FDG; ⁵¹Cr EDTA; ⁶⁷Ga citrate; ⁷⁵Se SeHCAT; ^99mTc DMSA, DTPA, RBC, IDA, large colloids, WBC, MAA, non-absorbable markers, pertechnetate, and phosphates and phosphonates; ¹²³I Hippuran and MIBG; ¹³¹I Hippuran and NP59; and ²⁰¹Tl thallous ion. Printing errors detected in ICRP Publication 53 are also listed.

Furthermore, the report reproduces with minor corrections and updates, and therefore supersedes, the information on 6 radiopharmaceuticals given in Addendum 1 to ICRP Publication 53: ³H neutral fat and fatty acids; ¹⁴C neutral fat and fatty acids; ⁶⁸Ga EDTA; and ^99mTc HM-PAO, MAG3, and MIBI.

There is an integrated index to all radiopharmaceuticals treated in ICRP publications so far, including a listing of effective doses per unit activity administered to adults.

This issue of the Annals of the ICRP also includes an Addendum to ICRP Publication 72 concerning age-dependent doses to members of the public from intakes of radionuclides.

This is an Addendum to ICRP Publication 72 concerning age-dependent doses to members of the public from intakes of radionuclides. It provides inhalation dose coefficients for labelled methane for members of the public, jointly prepared by two Task Groups of ICRP Committee 2.